Optometrist

Now Available – XDEMVY™ (lotilaner ophthalmic solution) 0.25%, the First and Only FDA Approved Treatment for Demodex Blepharitis

Demodex blepharitis impacts approximately 25 million eye care patients in the U.S. – or 1 out of every 12 adults. XDEMVY…

10 months ago

Association for Pediatric Vision Announces a Free Vision Screening Training Offered Nationwide

TAMPA, FL / ACCESSWIRE / August 21, 2023 / The Association for Pediatric Vision, a program of Lions World Vision…

10 months ago

Virginia’s Largest Ophthalmology, Optometry Clinic, and Storefront Transitions to eClinicalWorks Vision Solutions

50+ provider Virginia Eye Institute deploys eClinicalWorks EHR and healow patient engagement solutionsWESTBOROUGH, Mass.--(BUSINESS WIRE)--eClinicalWorks®, the largest ambulatory cloud EHR,…

11 months ago

RetinalGeniX Technologies Inc. Granted Patent for Patient Home Monitoring and Physician Alert System for Ocular Anatomy

Technology Enables Physicians to Remotely Make Pre-Diagnostic Assessment Regarding Whether an In-Person Diagnostic Examination of Ocular Anatomy is WarrantedPETALUMA, Calif.,…

11 months ago

Nicox Estimates Potential Annual Global Net Sales for NCX 470 of over $300 million

Press ReleaseNicox Estimates Potential Annual Global Net Sales for NCX 470 of over $300 millionNCX 470 therapeutic profile positively received…

12 months ago

Ocuphire Announces FDA Acceptance of New Drug Application and PDUFA Date of September 28, 2023 for Nyxol® Eye Drops for Reversal of Mydriasis

If Approved Later This Year, Nyxol Could be the Only Commercially Available Eye Drop for Reversal of DilationFARMINGTON HILLS, Mich.,…

1 year ago

Eye On Health Phoenix Offers New Expert Diabetic Eye Care Exams In Phoenix, Arizona

Phoenix, Arizona, Nov. 28, 2022 (GLOBE NEWSWIRE) -- Eye on Health Phoenix was founded in 2013 by Dr. Balocca, an…

2 years ago

NEXGEL Develops New Hydrogel Patch to Treat Amblyopia

Patch Will Be Available to Ophthalmologists and Optometrists in 1H 2023 Global Amblyopia Market Expected to Reach Over $6 Billion…

2 years ago

AXIM Biotechnologies Celebrates Feature on the Vision is More Than 20/20™ Podcast

SAN DIEGO, July 21, 2022 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an…

2 years ago

Newly Launched Digital Platform for Optometrists Allows Patients to Safely Interact with Doctors

Opti-Xpres Offers Contactless Patient Scheduling, Paperwork, Payment Processing, and a Virtual Glasses Try-On Feature  PHOENIX – In an effort to…

4 years ago